CBD Life Sciences Inc (CBDLD)

[02opida]

SCOTTSDALE, AZ / ACCESSWIRE / November 9, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has developed a product that may aid consumers in many ways around the globe.

Our new PR-X 100MG per tablet supplement has been in development for several months and is finally ready to hit the shelves! This product has been created with all natural ingredients infused with the purest Full-Spectrum CBD Isolate on the market. It is also lab tested for potency and consistency. PR-X is designed for and may help with prostate health, urinary, & hair support. President & CEO Lisa Nelson states "This is a giant step in the right direction for the company as we are trying to always create new products that have never been seen before from any of our competitors. PR-X is expected to boost revenue significantly and we are currently contacting dispensaries & convenient stores around Arizona to push this specific product to the next level in a movement to promote overall health to the max!"